What is Kura Oncology's long-term debt?

Kura Oncology (KURA) reported long-term debt of $9.75M in Q1 2026.

How has Kura Oncology's long-term debt changed year-over-year?

Kura Oncology's long-term debt increased by 27.4% year-over-year, from $7.65M to $9.75M.

What is the long-term trend for Kura Oncology's long-term debt?

Over 4 years (2020 to 2025), Kura Oncology's long-term debt has grown at a 22.9% compound annual growth rate (CAGR), from $4.25M to $9.71M.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Kura Oncology KURA Long-Term Debt

Long-Term Debt at other companies

Johnson & JohnsonJNJ

$37.53B-2.2%

AmgenAMGN

$51.89B-3.9%

Nuvation BioNUVB

$47.33M—

Arcus BiosciencesRCUS

$100M+108%

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$942.78M+86.2%

Enterprise value$927.97M+95.5%

P/S13.2×+3.9×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's long-term debt?: Kura Oncology (KURA) reported long-term debt of $9.75M in Q1 2026.
How has Kura Oncology's long-term debt changed year-over-year?: Kura Oncology's long-term debt increased by 27.4% year-over-year, from $7.65M to $9.75M.
What is the long-term trend for Kura Oncology's long-term debt?: Over 4 years (2020 to 2025), Kura Oncology's long-term debt has grown at a 22.9% compound annual growth rate (CAGR), from $4.25M to $9.71M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.